Skip to search formSkip to main contentSkip to account menu

AS1411

Known as: AS 1411, AS-1411, Anti-Nucleolin Aptamer AS1411 
A 26-base guanine-rich oligodeoxynucleotide aptamer with potential apoptotic induction activity. Upon administration, anti-nucleolin aptamer AS1411… 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

AGRO 100
NCIt Antineoplastic Agent Terminology

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Silica nano supra-assembly for the targeted delivery of therapeutic cargo to overcome chemoresistance in cancer.
2018
2018
Photoactivated Specific mRNA Detection in Single Living Cells by Coupling "Signal-on" Fluorescence and "Signal-off" Electrochemical Signals.
The spatiotemporal detection of a target mRNA in a single living cell is a major challenge in nanoscience and nanomedicine. We… 
2018
2018
Dual radiosensitization and anti-STAT3 anti-proliferative strategy based on delivery of gold nanoparticle - oligonucleotide nanoconstructs to head and neck cancer cells.
Constitutively activated signal transducer and activator of transcription 3 (STAT3) factor is an important therapeutic target in… 
2018
2018
Cell Surface Nucleolin as a Promising Receptor for Effective AS1411 Aptamer-Mediated Targeted Drug Delivery into Cancer Cells.
BACKGROUND One of the major abundant proteins in the nucleous is nucleolin that overexpressed on the cytoplasmic membrane of… 
2017
2017
Label-free silicon nanodots featured ratiometric fluorescent aptasensor for lysosomal imaging and pH measurement.
2017
2017
A novel chemotherapy drug-free delivery system composed of three therapeutic aptamers for the treatment of prostate and breast cancers in vitro and in vivo.
2015
2015
Label-free electrochemical aptasensor constructed by layer-by-layer technology for sensitive and selective detection of cancer cells.
2015
2015
Tumor targeting with a 99mTc-labeled AS1411 aptamer in prostate tumor cells
Abstract AS1411, a 26-base guanine-rich oligonucleotide aptamer, has high affinity to nucleolin, mainly on tumor cell surfaces… 
2014
2014
Aptamer-nanoparticle bioconjugates enhance intracellular delivery of vinorelbine to breast cancer cells
Abstract Targeted uptake of therapeutic nanoparticles in cell- or tissue-specific manner is an attractive technology since they… 
2013
2013
Aptamer modification improves the adenoviral transduction of malignant glioma cells.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)